NO20002126L - Formulering med forlenget frigjøring - Google Patents

Formulering med forlenget frigjøring

Info

Publication number
NO20002126L
NO20002126L NO20002126A NO20002126A NO20002126L NO 20002126 L NO20002126 L NO 20002126L NO 20002126 A NO20002126 A NO 20002126A NO 20002126 A NO20002126 A NO 20002126A NO 20002126 L NO20002126 L NO 20002126L
Authority
NO
Norway
Prior art keywords
release formulation
extended release
formulation
extended
release
Prior art date
Application number
NO20002126A
Other languages
English (en)
Other versions
NO20002126D0 (no
Inventor
Deborah Marie Sherman
John Clifton Clark
John Ulrick Lamer
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25508423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20002126(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO20002126D0 publication Critical patent/NO20002126D0/no
Publication of NO20002126L publication Critical patent/NO20002126L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20002126A 1997-11-05 2000-04-26 Formulering med forlenget frigjøring NO20002126L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96432897A 1997-11-05 1997-11-05
PCT/US1998/023338 WO1999022724A2 (en) 1997-11-05 1998-11-03 Extended release formulation containing venlafaxin

Publications (2)

Publication Number Publication Date
NO20002126D0 NO20002126D0 (no) 2000-04-26
NO20002126L true NO20002126L (no) 2000-05-04

Family

ID=25508423

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002126A NO20002126L (no) 1997-11-05 2000-04-26 Formulering med forlenget frigjøring

Country Status (39)

Country Link
EP (1) EP1028718B1 (no)
JP (1) JP2001521892A (no)
KR (1) KR20010031797A (no)
CN (1) CN1278165A (no)
AR (1) AR014012A1 (no)
AT (1) ATE237320T1 (no)
AU (1) AU747978B2 (no)
BG (1) BG104397A (no)
BR (1) BR9813179A (no)
CA (1) CA2305242A1 (no)
CL (1) CL2004001705A1 (no)
CO (1) CO5011060A1 (no)
CZ (1) CZ20001659A3 (no)
DE (1) DE69813602T2 (no)
DK (1) DK1028718T3 (no)
EA (1) EA200000487A1 (no)
EE (1) EE04577B1 (no)
ES (1) ES2196620T3 (no)
GE (1) GEP20043198B (no)
HK (1) HK1029056A1 (no)
HR (1) HRP20000213B1 (no)
HU (1) HU225238B1 (no)
ID (1) ID26317A (no)
IL (1) IL135457A0 (no)
MA (1) MA24691A1 (no)
NO (1) NO20002126L (no)
NZ (1) NZ504460A (no)
PA (1) PA8462501A1 (no)
PE (1) PE128699A1 (no)
PL (1) PL341141A1 (no)
PT (1) PT1028718E (no)
SK (1) SK6472000A3 (no)
SV (1) SV1998000131A (no)
TR (1) TR200001232T2 (no)
TW (1) TW555568B (no)
UA (1) UA77145C2 (no)
UY (2) UY25234A1 (no)
WO (1) WO1999022724A2 (no)
ZA (1) ZA9810081B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2368083A1 (en) * 1999-04-06 2000-10-12 Sepracor Inc. Derivatives of venlafaxine and methods of preparing and using the same
DE60035579T2 (de) * 1999-05-20 2008-04-17 Elan Corp. Plc Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
EP1451145A1 (en) * 2001-12-05 2004-09-01 Wyeth Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
WO2003050074A1 (en) * 2001-12-13 2003-06-19 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
WO2003055475A1 (en) * 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
EP1485344A1 (en) 2002-03-28 2004-12-15 Synthon B.V. Venlafaxine besylate
AU2003226752A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Venlafaxine base
US6696496B2 (en) 2002-03-28 2004-02-24 Synthon Bv Low water-soluble venlafaxine salts
AU2003219117A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Extended release venlafaxine formulations
FR2845289B1 (fr) 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
CA2415154C (en) * 2002-12-24 2009-06-16 Biovail Laboratories Inc. Modified release formulations of selective serotonin re-uptake inhibitors
DE10350194B4 (de) * 2003-10-28 2005-11-10 Bioplanta Arzneimittel Gmbh Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen
TW200503670A (en) * 2003-03-28 2005-02-01 Sandoz Ag Venlafaxine compositions
EP1502587B1 (en) * 2003-07-30 2006-08-23 Pharmathen S.A. Sustained release formulation for Venlafaxine hydrochloride
HUP0303382A2 (hu) * 2003-10-10 2005-08-29 EGIS Gyógyszergyár Rt. Venlafaxin-hidroklorid-tartalmú pelletek
JP2007520547A (ja) 2004-02-04 2007-07-26 アレムビック・リミテッド ベンラファキシン塩酸塩の徐放性コーティングされた小型錠剤
US7776358B2 (en) 2004-07-22 2010-08-17 Synthon Ip Inc. Extended release venlafaxine besylate tablets
US20190083399A9 (en) * 2006-04-03 2019-03-21 Isa Odidi Drug delivery composition
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
CN102772390B (zh) * 2012-08-16 2014-01-08 乐普药业股份有限公司 一种盐酸文拉法辛缓释胶囊及其制备方法
FR3080278B1 (fr) * 2018-04-11 2021-04-30 Ghs Patents Ltd Procede de fabrication d'un spheroide de cannabidiol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
ZA9810081B (en) 2000-05-04
GEP20043198B (en) 2004-03-25
KR20010031797A (ko) 2001-04-16
NO20002126D0 (no) 2000-04-26
TW555568B (en) 2003-10-01
ES2196620T3 (es) 2003-12-16
TR200001232T2 (tr) 2000-12-21
CZ20001659A3 (cs) 2001-10-17
ID26317A (id) 2000-12-14
DE69813602T2 (de) 2003-11-06
EP1028718A2 (en) 2000-08-23
MA24691A1 (fr) 1999-07-01
HRP20000213A2 (en) 2000-12-31
WO1999022724A2 (en) 1999-05-14
AU747978B2 (en) 2002-05-30
PA8462501A1 (es) 2000-05-24
HU225238B1 (en) 2006-08-28
AR014012A1 (es) 2001-01-31
DK1028718T3 (da) 2003-07-28
ATE237320T1 (de) 2003-05-15
HRP20000213B1 (en) 2004-04-30
SK6472000A3 (en) 2000-11-07
AU1300399A (en) 1999-05-24
UA77145C2 (en) 2006-11-15
BR9813179A (pt) 2000-08-22
UY25234A1 (es) 2000-12-29
HUP0004287A3 (en) 2002-05-28
WO1999022724A3 (en) 1999-07-22
HUP0004287A2 (hu) 2002-04-29
CL2004001705A1 (es) 2005-06-03
PT1028718E (pt) 2003-07-31
JP2001521892A (ja) 2001-11-13
HK1029056A1 (en) 2001-03-23
EE200000212A (et) 2001-04-16
CN1278165A (zh) 2000-12-27
CO5011060A1 (es) 2001-02-28
IL135457A0 (en) 2001-05-20
EP1028718B1 (en) 2003-04-16
EA200000487A1 (ru) 2000-10-30
NZ504460A (en) 2003-01-31
BG104397A (en) 2001-02-28
CA2305242A1 (en) 1999-05-14
SV1998000131A (es) 1999-11-18
EE04577B1 (et) 2006-02-15
PE128699A1 (es) 2000-01-06
PL341141A1 (en) 2001-03-26
UY25692A1 (es) 2000-03-31
DE69813602D1 (de) 2003-05-22

Similar Documents

Publication Publication Date Title
BR9701304A (pt) Formulação de liberação prolongada
DK0973527T3 (da) Clarithromycinformuleringer med forlænget frigivelse
DK0922386T3 (da) Sammensætninger med reguleret frigivelse
NO20001631L (no) 2-metyl-tieno-benzodiazepin formulering
DK0789562T3 (da) Caffeinformulering med vedvarende afgivelse
MA24473A1 (fr) Formulations
FI973816A0 (fi) Polypropen med hoeg smaeltstyrka
FI970468A0 (fi) Anvaendningspraoksberoende bokstavsmatning med nummertangenter
NO20002126L (no) Formulering med forlenget frigjøring
ID29635A (id) Formulasi mikrokapsul
ID28698A (id) Formulasi antiparasit
DK0880892T3 (da) Midler med reguleret frigivelse
FI974269A0 (fi) Radiosaendare-mottagarestruktur med tvao frekvensomraoden
NO20001375L (no) Legemiddelformulering med kontrollert virkestoffrigivning
ID27655A (id) Formulasi mikrokapsul
DK1000079T3 (da) Hidtil ukendt formulering
FI972664A0 (fi) Foerseglad saeck med avluftning
DE69814051D1 (de) Trennmittel
DE69812401D1 (de) Schnellkupplung
ID23663A (id) Persiapan kaprolaktam
FI970405A0 (fi) Plattformad traeprodukt med skiktstruktur
FI974544A0 (fi) Anordning i en med manoeverplats foersedd lastkran
FI970017A0 (fi) Med lampeffekts maetning foersett reglerbart elektroniskt anslutningsorgan
NO972442D0 (no) Utlöseranordning
FIU970109U0 (fi) Pikalukko

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application